- Acquired by Stryker Corporation, Oct 2012
- Raised funding round
About
Surpass Medical is developing and commercializing next-generation flow diversion technology to treat brain aneurysms using a unique mesh design and delivery system. Overview. The Surpass NeuroEndoGraft represents the next-generation flow diversion device and delivery system designed to improve ease-of-use and safe and reliable patient outcomes. Historically, intracranial aneurysms have been treated with surgical clipping or coils. These approaches have limited efficacy, particularly in complex anatomies. The Surpass team believes that flow diverters provide a valuable therapeutic alternative to patients. Technology. The Surpass device is designed to occlude a brain aneurysm by redirecting blood flow, allowing the blood in the aneurysm sac to clot. The device is implanted through a minimally invasive catheter-based procedure. The fine wire braided device is designed to be sufficiently permeable to enable sustained blood flow into side branches, remodeling the arterial lumen and repairing the diseased arterial segment while preserving side branches. The device is made from a fine cobalt chromium self-expanding braided wire mesh. Twelve platinum wires are integrated to provide excellent radiopacity. The over-the-wire delivery system allows a choice of .014 micro-guidewires. The stentgraft is preloaded into a custom-designed microcatheter, creating a device that is highly stable and predictable, with remarkable reproducibility.
Funding history · 1 round · — total
Q&A
- What is Surpass Medical's primary focus?
- Surpass Medical is developing and commercializing next-generation flow diversion technology to treat brain aneurysms using a unique mesh design and delivery system.
- When was Surpass Medical founded?
- Surpass Medical was founded in September 2005.
- What is the current status of Surpass Medical?
- Surpass Medical was acquired by Stryker Corporation in October 2012 and is currently inactive.
- How many employees did Surpass Medical have at the time of its acquisition?
- Surpass Medical had 1-10 employees.
- What type of technology does Surpass Medical utilize?
- Surpass Medical's device is designed to occlude a brain aneurysm by redirecting blood flow, allowing the blood in the aneurysm sac to clot. It is implanted through a minimally invasive catheter-based procedure and is made from a fine cobalt chromium self-expanding braided wire mesh with integrated platinum wires for radiopacity.
- Who founded Surpass Medical?
- Ygael Grad is the founder of Surpass Medical.
- In which sector does Surpass Medical operate?
- Surpass Medical operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| facebook.com/stryker-corporation |
Identifiers & details
| Founded | 2005-9 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Acquired (Inactive) by Stryker Corporation on Oct 2012 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Stryker Corporation 2012-10
Radar intelligence
Patents
| EPO | 5 |
|---|